Ticker	Volume	Price	Price Delta
DJIA	15,335.30	-19.12	-0.12%
S&P 500	1,666.29	-1.18	-0.07%
Nasdaq	3,496.43	-2.53	-0.07%

Ticker

Volume

Price

Price Delta

DJIA

15,335.30

-19.12

-0.12%

S&P 500

1,666.29

-1.18

-0.07%

Nasdaq

3,496.43

-2.53

-0.07%

Ticker	Volume	Price	Price Delta
STOXX 50	2,824.50	+6.51	0.23%
FTSE 100	6,755.63	+32.57	0.48%
DAX	8,455.83	+57.83	0.69%

Ticker

Volume

Price

Price Delta

STOXX 50

2,824.50

+6.51

0.23%

FTSE 100

6,755.63

+32.57

0.48%

DAX

8,455.83

+57.83

0.69%

Ticker	Volume	Price	Price Delta
Nikkei	15,381.00	+20.21	0.13%
Hang Seng	23,389.10	-103.97	-0.44%
S&P/ASX 200	5,180.10	-28.94	-0.56%

Ticker

Volume

Price

Price Delta

Nikkei

15,381.00

+20.21

0.13%

Hang Seng

23,389.10

-103.97

-0.44%

S&P/ASX 200

5,180.10

-28.94

-0.56%

Exchange: KOSDAQ
Sector: Consumer, Non-cyclical
Industry: Healthcare-Services
Sub-Industry: Medical Labs&Testing Srv

Biotoxtech Co Ltd

+ Add to Watchlist

086040:KS

9,100 KRW 600 7.06%

Share this quote:

Post this quote on one of these sites:

Copy permanent URL

As of 02:00:01 ET on 05/21/2013.

Snapshot for Biotoxtech Co Ltd (086040)

Open:	8,620	Day's Range:	8,620 - 9,250	Volume:	407,255
Previous Close:	8,500	52wk Range:	4,080 - 10,950	1-Yr Rtn:	+91.58%

Stock Chart for 086040

No chart data available.

086040:KS 9,100

8,500

Interactive 086040 Chart

…

Previous Close

Key Statistics for 086040

Current P/E Ratio (ttm)	73.1452
Estimated P/E(12/2013)	-
Relative P/E vs. KOSPI	0.3198
Earnings Per Share (ttm)	124.0000
Est. EPS (12/2013)	-
Est. PEG Ratio	-
Market Cap (M KRW)	101,761.98
Shares Outstanding (M)	11.22
30 Day Average Volume	656,227
Price/Book (mrq)	4.1902
Price/Sale (ttm)	5.5794
Dividend Indicated Gross Yield	-%
Cash Dividend	-
Last Dividend
5 Year Dividend Growth	-
Next Earnings Announcement	03/14/2014

mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 086040

Revenue
Net Income (M/KRW)

Profit Margin (%)

Company Profile & Key Executives for 086040

Biotoxtech Co., Ltd. provides a variety of non-clinical testing services. The Company researches, tests, and evaluates biological safety in medicines, food, cosmetics, and various household products. Biotoxtech's testings include carcinogenic testing, transmutative testing, phototoxicity testing, immunotoxicity testing, and environmental toxicity testing.